Paul Raymond Beckett

This inventor holds 3 USPTO granted patents. Top assignee: British Biotech Pharmaceuticals Limited. Active years: 2006-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Raymond Beckett. Retrieved from https://idiyas.com/inventor/paul-raymond-beckett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

Average Co-Inventor Count = 4.6

ph-index = 1

Company Filing History:

3 out of 85

British Biotech Pharmaceuticals Limited

patents

Years Active: 2006-2008

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7323563 - Hydroxamic acid derivatives as antibacterials (2008-01-29),

2. 7173053 - N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections (2007-02-06),

3. 6992190 - Hydroxamic acid derivatives as antibacterials (2006-01-31),

Title: The Innovative Mind of Paul Raymond Beckett

Introduction: Paul Raymond Beckett is a distinguished inventor hailing from Oxford, GB, known for his groundbreaking contributions to various fields.

Latest Patents: Paul Raymond Beckett's latest patents include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and biotechnology.

Career Highlights: Throughout his illustrious career, Paul Raymond Beckett has been recognized for his exceptional problem-solving skills and innovative thinking, leading to numerous successful inventions that have revolutionized industries.

Collaborations: Paul Raymond Beckett has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and driving forward progress in the technological landscape.

Conclusion: Paul Raymond Beckett's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in the global innovation community.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]